The Role of Plants in Traditional Medicine and Current Therapy

Journal of Alternative and Complementary Medicine

Volumn 1, Issue 2, 1995, Pages 131-143

  Houghton, Peter J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CULTURAL ANTHROPOLOGY; DEVELOPING COUNTRY; DRUG INDUSTRY; DRUG SCREENING; ETHNOBOTANY; HUMAN; MEDICINAL PLANT; PHYTOTHERAPY; REPRODUCIBILITY; RESEARCH; REVIEW; SELF CARE;

DEVELOPING COUNTRIES; DRUG EVALUATION; DRUG INDUSTRY; ETHNOBOTANY; HUMANS; PHYTOTHERAPY; PLANTS, MEDICINAL; REPRODUCIBILITY OF RESULTS; RESEARCH; SELF CARE; WESTERN WORLD;

EID: 0029311765     PISSN: 10755535     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/acm.1995.1.131     Document Type: Article

References (58)

1. Akerele O. Medicinal plants: Policies and priorities. In: Akerele O, Heywood V, Synge H, eds. Conservation of medicinal plants. Cambridge: Cambridge University Press, 1991, p 3-8.
2. Allen D, Wright CW, Phillipson JD, Kirby GC, Washurse DC. The effectiveness of chloroquine as an antimalarial may be compromised by the co-administration of gra-ditional medicares. J. Pharm. Pharmacol. 1994;46:1044.
3. Balandrin MF, Klocke JA, Wurtele ES, Bollinger WH. Natural plant chemicals: Sources of industrial and medicinal materials. Science 1985, 228:1154-1160.
4. Barton JH. Ethnobotany and intellectual property rights in ethnobotany and the search for new drugs. Chichester: Wiley, 1994, p 214-228.
5. Bauer R, Wagner H. Echinacea species as potential immu-nostimulatory drugs in economic and medicinal plant research. In: Wagner H, Farnsworth NR, eds. London: Academic Press, 1991, p 253-322.
6. Bisset NC. Curare-botany, chemistry and pharmacology. Supl Acta Amazonica 1988;18:255-290.
7. Bisset NG. Herbal drugs and phytopharmaceuticals. Stuttgart; Medpharm, 1994.
8. Bradley PR. British herbal compendium. Bournemouth, UK: British Herbal Medicine Association, 1992.
9. Braquet P. Ginkgolides-chemistry, biology, pharmacology and clinical perspectives. Vol. 1. Barcelona: Prous, 1988.
10. Braquet P. Ginkgolides-chemistry, biology, pharmacology and clinical perspectives. Vol. 2, Barcelona: Prous, 1989.
11. Chan TYK, Chan JCN, Tomlinson B, Critchley AJH. Chinese herbal medicines revisited: A Hong Kong perspective. Lancet 1993;342:1532-1534.
12. CIBA Foundation Symposium 185. Ethnobotany and the search for new drugs. Chichester: Wiley, 1994.
13. Cos PA, Balick MJ. The ethnobotanical approach to drug discovery. Sci Am 1994;270:60-65.
14. De Smet PAGM. Toxicological outlook on the quality assurance of herbal remedies in adverse effects of herbal drugs 1. Berlin: Springer, 1992, p 1-29.
15. de Souza NJ. Rohitukine and forskolin: Second generation immunomodulatory, intraocular-pressure-lowering, and cardiotonic analogues. Kinghorn AD, Balandrin MF, eds. Human medicinal agents from plants.
16. American Chemical Society Symposium Series 534. 1993,p 331-340.
17. Editorial. Pharmaceuticals from plants: great potential, few funds. Lancet 1994;343:1513-1515.
18. Ekong RM, Kirby GC, Patel G, Phillipson JD, Warhurst DC. Comparison of the in vitro activities of quassinoids with activity against Plasmodium falciparum, Anisomy-cin and some other inhibitors of eukaryotic protein synthesis. Biochem Pharmacol 1990;40:297-301.
19. Fairbairn JW. Biological assay and its relation to chemical structure. Pharmacology 1976;14(suppl. 1):48-61.
20. Farnsworth NR, Soejarto DD. Potential consequences of plant extinction in the United States on the current and future availability of prescription drugs. Econ Bot 1985; 39:231-240.
21. Farnsworth NR, Soejarto DD. Global importance of medicinal plants. In: Akerele O, Heywood V, Synge H, eds. Conservation of medicinal plants. Cambridge: Cambridge University Press, 1991, p 25-52.
22. Fellows LE. Pharmaceuticals from traditional medicinal plants and others: Future prospects. In: Coombes JD, ed. New drugs from natural sources. London: IBC Technical Services, 1992, p 93-99.
23. Formukong EA, Evans AT, Evans FJ. The medicinal uses of cannabis and its constituents. Phytother Res 1989;3: 219-231.
24. Fowler MF. Plant tissue culture as a source of novel compounds. In: Coombes JD, ed. New drugs from natural sources. London: IBC Technical Services, 1992, p 72-80.
25. Gentry AH. Tropical forest biodiversity and the potential for new medicinal plants in human medicinal agents from plants. In: Kinghorn AD, Balandrin MF, eds. Human medicinal agents from plants. American Chemical Society Symposium Series 534.1993, p 13-26.
26. Grindley J. The natural approach to pharmaceuticals. Scrip 1993;December:30.
27. Halliwell B. Free radicals, antioxidants and human disease: Curiosity, cause or consequence? Lancet 1994; 344:721-724.
28. Hamann O. The joint lUCN-WWF plants conservation programme and its interest. Conservation of medicinal plants. In: Akerele O, Heywood V, Synge H, eds. Conversation of medicinal plants. Cambridge: Cambridge University Press, 1991, p 13-24.
29. Haynes RK, Vonwiller SC. Extraction of artemisinin and artemisinic acid: Preparation of artemether and new analogues. Trans Roy Soc Trop Med Hyg 1994;88(suppl
30. Huang PL, Huang PL, Huang P, Huang HI, Lee-Huang S. Developing drugs from traditional medicinal plants Chem Ind 1992;290-293.
31. Johnson ES, Kadam NP, Hylands DM, Hylands PJ. Efficacy of feverfew as a prophylactic treatment of migraine. Br Med J 1985;291:569-573.
32. King S, Tempesta MS. From shaman to human clinical trials: The role of industry in ethnobotany, conservation and community reciprocity in ethnobotany and the search for new drugs. Chichester, UK- Wiley, 1994 p 197-213.
33. Kleijnen J, Knipschild P. Ginkgo biloba. Lancet 1992a; 340:1136-1139.
34. Kleijnen J, Knipschild P. Ginkgo biloba for cerebral insufficiency. Br J Clin Pharmacology 1992b;34;352-358.
35. Lawson LD. Bioactive organosulphur compounds of garlic and garlic products: Role in reducing blood lipids. In: Kinghorn AD, Balandrin MF, eds. Human medicinal agents from plants. American Chemical Society Symposium Series 534. 1993, p 306-330.
36. Lednicer D, Snader KM. Plants and other organisms as a source of anti-human immunodeficiency (HIV) Drugs. In: Wagner H, Farnsworth NR, eds. Economic and medicinal plant research. London: Academic Press, 5:p 1-20.
37. Li Wan Po A. Evening primrose oil. Pharm J 1991;246: 676-678.
38. Lozoya X, Chadwick DJ, Marsk J, eds. Two decades of Mexican ethnobotany and research on plant-derived drugs Ethnobotany and the Search for New Drugs. Chichester, UK: Wiley, 1994, p 130-152.
39. McAlpine D. Natural remedies move the European market. Pharamceutical Marketing 1992;4:24-26.
40. Micozzi M, Moon TE. Macronutrients: Investigating their role in cancer. New York: Marcel Dekker, 1992.
41. Mills SY. The essential book of herbal medicine. London: Penguin, 1991.
42. O'Neill MJ, Lewis JA. The renaissance of plant research in the pharmaceutical industry. In: Kinghorn AD, Balandrin MF, eds. Human medicinal agents from plants. American Chemical Society Symposium Series 534. 1993, p 48-55.
43. O.T.C. Bulletin. Harnessing the potential of herbal remedies. 1993;August 27:12-13.
44. Palevitch D. Agronomy applied to medicinal plant conservation. In: Akerele O, Heywood V, Synge H, eds. Conservation of medicinal plants. Cambridge: Cambridge University Press, 1991, p 167-178.
45. Perharic L, Shaw D, Murray V. Toxic effects of herbal medicines and food supplements. Lancet 1993;342: 180-181.
46. Perharic L, Shaw D, Colbridge M, House I, Leon C, Murray V. Toxicological problems resulting from exposure to traditional remedies and food supplements. Drug Safety 1994;11:284-294.
47. Pezzuto JM. Cancer chemopreventive agents: From plant materials to clinical intervention trials. In: Kinghorn AD, Balandrin MF, eds. Human medicinal agents from plants. American Chemical Society Symposium Series 534. 1993, p 205-217.
48. Phillipson JD, Anderson LA. Ethnopharmacology and Western medicine J. Ethnopharmacol 1989;25:61-72.
49. Plotkin MJ. Traditional knowledge of medicinal plants- the search for new jungle medicines. In: Akerele O, Heywood V, Synge H, eds. Conservation of medicinal plants. Cambridge: Cambridge University Press, 1991, p 53-64.
50. Principe PP. Valuing the biodiversity of medicinal plants. In: Akerele O, Heywood V, Synge H, eds. Conservation of medicinal plants. Cambridge: Cambridge University Press, 1991, p 79-124.
51. Reuter HD. What are the possibilities and limits of therapy with European native drugs in modern clinical medicine? J Ethnopharmacology 1992;32:187-193.
52. Schumacher HM. Biotechnology in the production and conservation of medicinal plants. In: Akerele O, Heywood V, Synge H, eds. Conservation of medicinal plants. Cambridge: Cambridge University Press, 1991, p 179-198.
53. Scott BC, Paganga G, Aruoma OI, Halliwell B, Rice-Evans CA. The plant-derived antioxidants quercetin and (+) catechin operate synergistically in protecting against low density lipoprotein oxidation and a-tocohpherol depletion. Biochem J (In press).
54. Sheehan MP, Rustin MHA, Atherton DJ, Buckley C, Harris DJ, Brostoff J, Ostlere L, Dawson A. Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis: Results of a double-blind placebo-controlled study. Lancet 1992;340:13-17.
55. Suschitzy JL. Antiasthmatic agents: The discovery of intal. Chemistry in Britain 1987;23:554-555.
56. Waigh RD. The chemistry behind atracurium. Chemistry in Britain 1988;24:1209-1212.
57. Weiss RF. Herbal medicine. Stuttgart: Hippokrates, 1988.
58. WHO. The role of artemisinin and its derivatives in the current treatment of malaria. WHO/MAL/94.1067.